UFP Technologies (UFPT) Expected to Release Quarterly Earnings on Monday

Key Points

• UFP Technologies is expected to report Q3 2026 results after the market closes on Monday, November 2. Analysts forecast earnings of $2.49 per share on revenue of $166.89 million, with the earnings call scheduled for November 3.
• The company exceeded expectations in its previous quarter, reporting $2.92 EPS versus the $2.31 consensus and revenue of $173.96 million versus estimates of $159.38 million.
• UFPT shares opened at $295.78, near their 50-day average and below the 52-week high of $338.71. Analyst sentiment remains a consensus “Hold,” while insiders have sold more than $8.17 million of stock over the past 90 days.

UFP Technologies (NASDAQ:UFPT - Get Free Report) is anticipated to announce its Q3 2026 results after the market closes on Monday, November 2nd. Analysts expect the company to announce earnings of $2.49 per share and revenue of $166.89 million for the quarter. Parties may visit the company's upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 3, 2026 at 8:30 AM ET.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last issued its earnings results on Monday, August 3rd. The industrial products company reported $2.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.31 by $0.61. UFP Technologies had a net margin of 11.45% and a return on equity of 18.42%. The firm had revenue of $173.96 million for the quarter, compared to analysts' expectations of $159.38 million. On average, analysts expect UFP Technologies to post $10.54 EPS for the current fiscal year and $12.05 EPS for the next fiscal year.

UFP Technologies Stock Performance

Shares of UFPT stock opened at $295.78 on Monday. The company has a market cap of $2.29 billion, a P/E ratio of 31.87 and a beta of 1.04. The business has a 50 day moving average of $293.56 and a two-hundred day moving average of $257.63. UFP Technologies has a 52 week low of $173.86 and a 52 week high of $338.71. The company has a quick ratio of 1.72, a current ratio of 3.00 and a debt-to-equity ratio of 0.26.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Weiss Ratings raised UFP Technologies from a "hold (c)" rating to a "hold (c+)" rating in a report on Wednesday, August 5th. Wall Street Zen upgraded UFP Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Two equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, UFP Technologies currently has a consensus rating of "Hold".

Insider Activity

In related news, Director Marc D. Kozin sold 7,000 shares of UFP Technologies stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $304.50, for a total value of $2,131,500.00. Following the sale, the director directly owned 21,112 shares in the company, valued at $6,428,604. This trade represents a 24.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Symeria Hudson sold 1,926 shares of the business's stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $324.58, for a total transaction of $625,141.08. Following the transaction, the director directly owned 1,225 shares of the company's stock, valued at $397,610.50. The trade was a 61.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 25,919 shares of company stock worth $8,173,084 over the last ninety days. Insiders own 4.59% of the company's stock.

UFP Technologies Company Profile

UFP Technologies, Inc NASDAQ: UFPT is a designer and manufacturer of engineered components, assemblies and packaging solutions, with a primary focus on the medical device and healthcare markets. The company works with original equipment manufacturers and other customers to develop products used in surgical, orthopedic, diagnostic, wound-care and other medical applications.

Its capabilities include converting and fabricating advanced materials such as foams, films, laminates, textiles and composites, as well as molding plastics and producing complex assembled products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.